Introduction
In the UK, as many as one third of all pregnancies are thought to be unintended [1, 2] and over half 44 of these end in termination [1, 2] . The US also reports high rates of unintended pregnancy and 45 abortion [3] . EC gives women a second chance to prevent unintended pregnancy. The copper 46 intrauterine device (IUD) is the most effective EC but is not widely used. It is unpopular with women 47 due to the invasive procedure and requires skilled clinicians to insert it [4] . Oral EC is more 48 commonly used and is more easily obtainable. However, at the population level, oral EC has not 49 reduced the number of unintended pregnancies [5] . Whilst this may be due to women failing to use 50 EC after every act of unprotected sexual intercourse [6] , it may also be because current oral EC is not 51 sufficiently effective. 52
The current oral EC methods available in Europe and the US are levonorgestrel and ulipristal acetate. 53
Clinical trials have shown that when taken within 120 hours of unprotected sexual intercourse, these 54 methods resulted in an observed pregnancy rate of 2.6% and 1.8% respectively. This compares to an 55 expected pregnancy rate of 5.4% and 5.5% respectively, suggesting that these methods might only 56 prevent between approximately one half and two thirds of pregnancies [7] . The only confirmed 57 mechanism of action of these oral methods is through delaying ovulation [8] . 58
The accumulated evidence suggests that while there is scope and considerable enthusiasm among 59 the research community to develop a more effective oral EC pill that acts both pre-and post-60 fertilization, moral objections continue to be expressed by "many opponents" about the use of EC 61 [9] . Of the two post-fertilization methods, namely preventing or disrupting implantation, the latter, 62 which occurs once the implantation process has begun, is defined in the UK and US as abortion, not 63 contraception [10] . Expanding the emergency options available to women throughout the menstrual 64 cycle by the development of a new post-fertilization fertility control drug would raise political and 65 ethical challenges. In this paper we have used the term 'EC' to describe potential interventions 66 which (a) inhibit ovulation, (b) prevent implantation or (c) disrupt implantation.
reproductive age in Edinburgh, Scotland attending a family planning service. These studies focused 69 on women's views on the use of a hypothetical once-a-month contraceptive pill. The combined 70 findings of these surveys showed that a pill that worked through inhibiting ovulation was acceptable 71 to the majority of respondents. A pill that prevented implantation was acceptable to half of 72 respondents and a pill which disrupted implantation was acceptable to a smaller proportion. Women 73 surveyed in China, Romania, Slovenia and South Africa reported a similar pattern of acceptability 74 [11, 12] . 75
No recent data report women's views on acceptability of oral EC and its mechanism of action. The 76 primary aim of this study was to report on the acceptability of oral EC posited to inhibit ovulation, 77 prevent implantation or disrupt implantation and whether women would accept a 'missed menses 78 pill' (a pill that women would take only if a period was late by a few days). We also sought to 79 establish any relationship between the women's characteristics and their responses. 80
Materials and Methods 81
We designed a questionnaire for self-completion by women attending various sexual and 82 reproductive healthcare (SRH) settings in Edinburgh, UK. We based it upon previous surveys [11, 12, 83 13] and we piloted it for understandability and ease of completion amongst women (n=10) attending 84 a sexual health clinic. Based on their feedback, we then made some small changes to the 85 questionnaire. 86
In the introduction we explained that women were under no obligation to complete the 87 questionnaire, that they could leave any parts of it blank and that responses were anonymous and 88 strictly confidential. 89
Women answered 17 questions in three sections. The first section asked whether 'in theory' they 90 would consider using a pill which worked in each of three different ways (a) by stopping or delaying an egg being released (inhibiting ovulation), (b) by preventing a very early fertilised egg attaching to the lining of the womb (preventing implantation) or (c) by dislodging a very early fertilised egg from 93 the lining of the womb before a period is missed (disrupting implantation). They also reported 94 whether they would use a missed-period pill. The response categories were 'yes', 'no' or 'uncertain'. 95
The second section asked about previous contraceptive use, including previous oral EC and use of 96 intrauterine contraception (IUC) for EC. The third section asked respondents specific questions on 97 whether they were in a sexual relationship, held any strong religious beliefs and had in the past held 98 any strong views against abortion, in addition to questions on their previous reproductive history 99 (including previous births and abortions) and their age. The terms 'strong beliefs' and 'strong views' 100 were not defined as these are subjective. As in previous surveys [14] , we asked whether women had 101 in the past held any strong views against abortion, rather than asking about their current views, 102 mindful of the potential sensitivity of their immediate situation. They were also asked for the first 103 four characters of their postcode pertaining to area, district and sector, to obtain a Carstairs 104 deprivation category score (2011) (a marker of deprivation based on postcode area of residence in 105 Scotland) [15] . 106
The questionnaire was distributed between February 2015 and August 2015 and given to three 107 groups of women in Edinburgh attending: (i) five independent community pharmacies across the city 108 requesting EC, (ii) clinics at the SRH service for insertion of IUC (as a regular method of 109 contraception) and (iii) clinics at the SRH service for termination of pregnancy (TOP). 110
These respective groups represented women choosing: (a) to use oral EC, (b) to use a method of 111 contraception that prevents implantation and (c) to terminate (disrupt) a pregnancy that had already 112
implanted. 113
At each pharmacy, duty pharmacists gave out a questionnaire when a woman requested EC. In the 114 their questionnaire in an opaque, sealed envelope and placed it in a secure box. The questionnaires 117 were collected regularly and stored securely. 118
The National Health Service (NHS) ethical officer reviewed the survey and protocol and confirmed 119 that ethical committee approval was not required. The Quality Improvement Team for SRH and the 120 local NHS Research and Development Office approved the project. 121
Statistical analysis 122
The data were coded and recorded in Microsoft Excel and responses analysed for each group and for 123 all respondents. IBM Statistical Package for the Social Sciences (SPSS), version 22 was used for 124 statistical analysis. To allow statistical comparison between age groups, we defined four age 125 categories (≤19, 20-24, 25-34 and ≥35 years old) and created deprivation category groupings (1-2 = 126 affluent, 3-5 = moderate, 6-7 = deprived). We based these on previous studies [13, 16] . 127
We conducted statistical comparisons of the ages of women across the cohorts using unpaired t-128 tests. In testing for associations between categorical variables, the chi-squared test of association or, 129
where appropriate, Fisher's exact test was performed. The chi-squared test of linear trend was used 130 to test for a monotonic trend in acceptability across the different hypothetical mechanisms of action 131 according to when they acted during the reproductive cycle. 132
We assumed a significance level of 0.05 for all univariable analyses and of 0.1 at the final stage of 133 the multivariable analyses in the identification of possible independent predictors of acceptability. 134
This was carried out separately for each of the acceptability categories: inhibits ovulation, prevents 135 ovulation, disrupts implantation and missed period pill. We assumed the weaker significance level 136 for the multivariable models because in such models, more stringent significant levels carry the risk 137 of ruling out factors of practical importance [17] .
A total of 419 out of 458 women responded to the survey (91% response rate): (a) for the EC group 140 104 out of 104 (100% response rate), (b) for the TOP group 207 out of 238 (87% response rate) and 141 (c) for the IUC group 108 out of 116 (93% response rate). Table 1 shows the demographic 142 characteristics of the women in each group. Eight percent (31/407; 95% CI, 0.05-0.11) of women in 143 all groups indicated that they held strong religious beliefs and 17% (69/403; 95% CI, 0.14-0.21) 144 indicated that they previously held strong views against abortion. 145 Table 1 shows that 63% (263/417) of women had previously used oral EC; however, the TOP group 146 was less likely than the EC group to have done so. In total, only 3% (13/414) of the women had 147 previously had an IUC fitted as EC (95% CI, 0.02-0.05). 148 Table 2 shows that in all groups the acceptability of an EC pill decreased as the posited mechanism 149 of action during the reproductive cycle moved from inhibiting ovulation to preventing implantation 150 and then to disrupting implantation. More women requesting TOP considered an EC pill that disrupts 151 implantation to be acceptable, compared to those attending for IUC insertion. Table 2 shows that 152 women requesting a TOP found a missed-period pill more acceptable than the EC and the IUC groups 153 (77% TOP vs 59% EC vs 44% IUC). 154
There was statistical evidence for an association between acceptability of the hypothetical pills and 155 each of the following factors: previous EC use, being in a sexual relationship, previous abortion, 156 parity, strong religious beliefs and previously holding strong views against abortion (Table 3) . 157
We found a lack of statistical evidence for an association between acceptability of an EC method of 158 action and any one of deprivation category score, age or the other factors measured (Tables 4a-d) . 159
For the EC categories prevents implantation and missed period pill, the model diagnostics did not 160 support use of a binary logistic regression model to represent the independent effects of potential 161 predictor variables from this study. For example, for the EC category prevents implantation, inclusion of the variables for holding strong religious beliefs and previously holding strong views against abortion in the same model removed the statistical significance of the latter variable, leaving only 164 the former independent variable for consideration. The adjusted odds ratios and corresponding 90% 165
CIs for the regression models pertaining to the EC categories inhibits ovulation and disrupts 166 implantation are provided in Table 5 . 167
Discussion 168
The majority of women who took part in this survey indicated that they would be willing to consider 169 the use of an EC pill with the posited mechanisms of action (inhibiting ovulation, preventing 170 implantation or disrupting implantation). Although most women would also use a missed-period pill, 171 the acceptability of this and of a pill which acted by disrupting implantation was less than for EC that 172 worked by inhibiting ovulation. 173
Overall, one in ten women were not accepting of a pill which worked by inhibiting ovulation. The IUC 174 group was not unanimously accepting of an EC pill which worked by preventing implantation. 175
Women's reasons for not accepting the posited mechanisms of action were not determined and this 176 is an area that requires further investigation. 177 Perhaps unsurprisingly, women requesting an abortion were more likely to find a pill that disrupted 178 implantation or a missed-period pill acceptable, compared to those who were requesting an IUC. 179
Women at the IUC clinic were choosing long-acting reversible contraception and so might not need 180 to use oral EC. One might hypothesise that the TOP group would be more willing to take effective EC 181 regardless of its mechanism, to avoid having an abortion or because they are accepting of abortion. 182
Based on the multivariable analyses, this study presents a number of important findings (Table 5)  183 concerning acceptability of EC pills for women attending the types of healthcare clinics in Edinburgh 184
represented in this study. Firstly, it is estimated that women who have previously held strong views 185 against abortion are about 75% less likely to consider a hypothetical pill which disrupts implantation as acceptable rather than unacceptable than women who have not or are uncertain whether they 187 have held such views previously. A similar result applies for acceptability of a hypothetical pill which 188 inhibits ovulation. 189
Additionally, it is estimated that women from the above population are about twice as likely to 190 accept a hypothetical pill which disrupts implantation if they have previously had an abortion in 191 contrast to those who have not. A similar result applies for acceptability of a hypothetical pill which 192 inhibits ovulation on comparing women who have previously used EC with those who have not used 193 EC or are uncertain about previous use of EC. 194 More generally, it is implicit from the results of the diagnostic testing of the binary logistic regression 195 models for the acceptability categories inhibits ovulation and disrupts implantation that there is a 196 call for a systematic investigation of potential additional predictive factors of acceptability. This 197 would produce more valid predictive models which can explain variability in acceptability across 198 eligible respondents far better and improve on the classification accuracy of these models. For the 199 categories prevents implantation and missed period pill, for which no multivariable model was 200 forthcoming, it is possible that similar work is needed. 201
A strength of this study is that a considerable number of women from different healthcare settings 202 were surveyed. It also provides comparative data, as the women were from the same city, Edinburgh 203 and some of them were attending a similar setting (a family planning clinic) as in previous studies 204 [11, 12] . A limitation of this study is that the questionnaire asked what the women would do 'in 205 theory', which may not translate into what they would do 'in real life'. Research in the pharmacy 206 setting can be challenging [13] and it was not possible to ensure that the pharmacists distributed the 207 questionnaire to all women seeking EC so the data may not be representative. The survey was only 208 conducted in Edinburgh, amongst subgroups of women. In the future it would be important to have 209 multi-site and multi-population studies elsewhere to determine if women in the wider population 210 hold similar views. contraceptive [11, 12] , our study concludes that a higher proportion of women would be accepting 213 of a pill that prevents implantation (83% vs 54%), a pill that disrupts implantation (75% vs 18%) or a 214 missed period pill (64% vs 28%). This suggests that attitudes towards the mechanisms of action of 215 contraception have changed. 216 A method that works by disrupting implantation would currently raise ethical and legal issues in 217 many settings including the UK and US as it would be classed as abortion. However, this method 218 would currently be permissible in countries where 'menstrual induction' (i.e. evacuation of the 219 uterus in women who have delayed menses but no laboratory confirmation of pregnancy) is 220 permitted, such as China [18] . In the 1980's, French scientists and clinicians, engaged in 221 contraceptive research using PRMs, coined the term 'contragestion' to describe a method that could 222 remain effective after ovulation to prevent or disrupt the establishment of a very early pregnancy at 223 the end of the luteal phase of the cycle [19, 20] . Perhaps this terminology could be used in future to 224 convey the concept of an 'emergency' method that works throughout the cycle in order to prevent 225 unintended pregnancy. 226
Our study suggests that women in the above healthcare settings may be willing to consider oral EC 227 which works either by inhibiting ovulation, preventing implantation or disrupting implantation. In 228 addition, women may also be prepared to use a missed-menses pill to prevent unintended 229 pregnancy. However, our study was of limited scope and further work on the views of women in the 230 wider population is needed. This is important, as the development of such drugs to prevent 231 pregnancy is likely to raise political and ethical challenges, particularly in relation to disruption of 232 implantation. 233
We would like to thank the pharmacists and staff, both at the Edinburgh pharmacies Boots 235 mean differences were 3.47 (95% CI, 2.15-4.79; p < 0.001) and 11.31 (95% CI, 9.33-13.29; p < 0.001), 248 respectively. b Women from the IUC group were on average older than the women in the other groups (see above 250
for comparison to EC group; the mean difference in comparison to TOP group was 7.84 (95% CI, 251 5.85-9.84; p<0.001)) and had the largest age range. 252 c A woman from the EC group was more likely to live in a deprived area compared to a woman from 253 the IUC group (OR, 11.74; 95% CI, 4.47-30.84; p<0.001) and a woman from the TOP group (OR, 4.04; 254 95% CI, 2.12-7.69; p<0.001). 255 d A woman from the TOP group was more likely to live in a deprived area compared to a woman 256 from the IUC group (OR, 2.91; 95% CI, 1.15-7.38; p=0.033). 257 e A woman from the TOP group was less likely to have used oral EC in the past compared to a woman 258 from the EC group (OR, 0.56; 95% CI, 0.34-0.93; p = 0.032). 259
depending on their mechanism of action and to using a missed-period pill. 261
Group
Inhibits ovulation (n (%)) 1 EC: Emergency contraception; 2 TOP: Termination of pregnancy; 3 IUC: Intrauterine contraception 262 a There was an absence of statistical evidence for a difference between groups for acceptability of EC 263 except between women requesting abortion (TOP) and women attending for IUC for a method that 264 disrupts implantation (OR, 2.19; 95% CI, 1.30-3.69; p=0.004). 265 b A woman requesting a TOP was more likely to find a missed-period pill acceptable than a woman 266 from the EC group (OR, 2.41; 95% CI, 1.44-4.01; p=0.001) and the IUC group (OR, 4.27; 95% CI, 2.58-267 7.05; p < 0.001). 268 c The proportion of women who considered a potential EC pill as acceptable decreased as the 269 mechanism of action moved from inhibiting ovulation, to preventing implantation, to disrupting 270 implantation ( 2 = 27.853, p < 0.001).
depending on their mechanism of action and b) a missed-period pill 273
Factor N (%) OR and 95% CI p-value Inhibits ovulation
Previous use of EC vs. no or uncertain previous use of EC 
